Rationale
We developed a new high‐throughput method to analyze tegafur (FT) and 5‐fluorouracil (5‐FU) in tear and plasma samples using hydrophilic interaction liquid chromatography (HILIC)/tandem mass spectrometry (MS/MS).
Methods
The tear samples (10 μL) spiked with FT, 5‐FU, and 5‐chlorouracil (internal standard) were diluted using 40 μL of 2 M ammonium acetate and 250 μL of acetonitrile with 2% formic acid; 20 μL of plasma spiked with the two drugs and internal standard was diluted with 80 μL of 2 M ammonium acetate and 500 μL of acetonitrile with 2% formic acid. After centrifugation, the clear supernatant extract (15 μL) was directly injected into the HILIC/MS/MS instrument, and each drug was separated on a Unison UK‐Amino column (50 mm × 3 mm i.d., 3 μm particle size) with a linear gradient elution system composed of 10 mM ammonium acetate (pH 6.8) and acetonitrile at a flow rate of 0.7 mL/min. We performed quantification by multiple reaction monitoring (MRM) with negative‐ion atmospheric‐pressure chemical ionization.
Results
Distinct peaks were observed for the drugs on each MRM channel within 2 min. The regression equations showed good linearity within the range 0.04–4.0 μg/mL for the tear and plasma samples with detection limits at 0.02–0.04 μg/mL. Recoveries for target analytes (FT and 5‐FU) for the tear and plasma samples were in the 94–128% and 94–104% ranges, respectively. The intra‐ and inter‐day coefficients of variation for the two drugs were lower than 10.8%. The accuracies of quantitation were 97–115% for both samples.
Conclusions
We established a high‐throughput, reproducible, and practical procedure for analyzing FT and 5‐FU in human tear and plasma samples using HILIC/MS/MS analysis with an aminopropyl‐bonded mixed‐mode separation column. This method can be applied to the high‐throughput routines used in clinical analyses.